Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSPB1 | P04792 | 1/20 | 0.50 |
| ▸ | CA1 | P00915 | 3/20 | 0.48 |
| ▸ | CA2 | P00918 | 3/20 | 0.48 |
| ▸ | CA9 | Q16790 | 1/20 | 0.48 |
| ▸ | CES2 | O00748 | 1/20 | 0.48 |
| ▸ | CES1 | P23141 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.45 |
| ▸ | ACHE | P22303 | 2/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | THRB | P10828 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5847946 | 0.83 | HSPB1 (0.50) | HSPB1CA1CA2CA9CES2 | |
| SCHEMBL8432 | 0.81 | HSPB1 (0.52) | HSPB1CA1CA2CA9CES2 | |
| SCHEMBL821250 | 0.79 | HSPB1 (0.50) | HSPB1CA1CA2CA9CES2 | |
| SCHEMBL12111966 | 0.77 | TSHR (0.55) | CES2CES1KMT2AALDH1A1ACHE | |
| SCHEMBL24787 | 0.76 | CA1 (0.32) | CA1CA2CA9ALDH1A1CYP3A4 | |
| Water SCHEMBL28241270 | 0.76 | ALDH1A1 (0.68) | CA1CA2CA9CES1MEN1 | |
| Water SCHEMBL27300423 | 0.76 | ALDH1A1 (0.68) | CA1CA2CA9CES1MEN1 | |
| SCHEMBL11802013 | 0.76 | HSPB1 (0.47) | HSPB1CA1CA2CA9CES2 | |
| Thiocyanic Acid SCHEMBL29001101 | 0.75 | ALDH1A1 (0.54) | CA1CA2CA9CES1MEN1 | |
| 4,4'-Oxybis(Nitrobenzene) SCHEMBL134332 | 0.75 | HSPB1 (0.79) | HSPB1CA1CA2CA9CES2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 225 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240230545-A9 | ACTIVATED-QUENCHED POLYSACCHARIDE AND IMPROVED METHODS FOR QUANTIFICATION OF POLYSACCHARIDE IN A VACCINE COMPOSITION | BIOLOGICAL E LIMITED (IN) | 2024-07-11 | — | — | US | claimed |
| US-20240133818-A1 | ACTIVATED-QUENCHED POLYSACCHARIDE AND IMPROVED METHODS FOR QUANTIFICATION OF POLYSACCHARIDE IN A VACCINE COMPOSITION | BIOLOGICAL E LTD (IN) | 2024-04-25 | — | — | US | claimed |
| EP-4297776-A1 | ACTIVATED-QUENCHED POLYSACCHARIDE AND IMPROVED METHODS FOR QUANTIFICATION OF POLYSACCHARIDE IN A VACCINE COMPOSITION | Biological E Limited (IN) | 2024-01-03 | — | — | EP | claimed |
| WO-2022180648-A1 | ACTIVATED-QUENCHED POLYSACCHARIDE AND IMPROVED METHODS FOR QUANTIFICATION OF POLYSACCHARIDE IN A VACCINE COMPOSITION | BIOLOGICAL E LIMITED (IN) | 2022-09-01 | — | — | WO | claimed |
| EP-4025246-A2 | IMMUNOGENIC COMPOSITIONS AGAINST ENTERIC DISEASES AND METHODS FOR ITS PREPARATION THEREOF | Serum Institute Of India Private Limited (IN) | 2022-07-13 | — | — | EP | claimed |
| CN-114728053-A | Immunogenic compositions against intestinal disease and process for preparing same | 印度血清研究所私人有限公司 | 2022-07-08 | — | — | CN | claimed |
| WO-2021044436-A2 | IMMUNOGENIC COMPOSITIONS AGAINST ENTERIC DISEASES AND METHODS FOR ITS PREPARATION THEREOF | SERUM INSTITUTE OF INDIA PRIVATE LIMITED (IN) | 2021-03-11 | — | — | WO | claimed |
| CN-104428008-B | Multivalent meningococcal conjugates and methods of making conjugates | 美国政府(由卫生和人类服务部的部长所代表) | 2020-10-09 | — | — | CN | claimed |
| US-9956278-B2 | Multivalent meningococcal conjugates and methods for preparing conjugates | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2018-05-01 | — | — | US | claimed |
| US-20160331824-A1 | MULTIVALENT MENINGOCOCCAL CONJUGATES AND METHODS FOR PREPARING CONJUGATES | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPT. OF HEALTH AND HUMAN SERVICES (US) | 2016-11-17 | — | — | US | claimed |
| EP-1015027-B1 | PROCESS FOR PREPARING CONJUGATE VACCINES INCLUDING FREE PROTEIN | LEES ANDREW (US) | 2008-06-25 | — | — | EP | claimed |
| EP-0814833-B1 | PRODUCING IMMUNOGENIC CONSTRUCTS USING SOLUBLE CARBOHYDRATES ACTIVATED VIA ORGANIC CYANYLATING REAGENTS | JACKSON H M FOUND MILITARY MED (US) | 2003-05-28 | — | — | EP | claimed |
| US-20020054879-A1 | Process for preparing conjugate vaccines including free protein and the conjugate vaccines, immunogens, and immunogenic reagents produced by this process | HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MED. | 2002-05-09 | — | — | US | claimed |
| US-6248334-B1 | COMPLEXING PROTEIN AND POLYSACCHARIDE | HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE | 2001-06-19 | — | — | US | claimed |
| US-5849301-A | Producing immunogenic constructs using soluable carbohydrates activated via organic cyanylating reagents | HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE (US) | 1998-12-15 | — | — | US | claimed |
| EP-0814833-A1 | PRODUCING IMMUNOGENIC CONSTRUCTS USING SOLUBLE CARBOHYDRATES ACTIVATED VIA ORGANIC CYANYLATING REAGENTS | Lees, Andrew (US) | 1998-01-07 | — | — | EP | claimed |
| US-5693326-A | COUPLING BACTERIAL POLYSACCHARIDE AND A PROTEIN TO FORM A IMMUNOSTIMULANT | HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE (US) | 1997-12-02 | — | — | US | claimed |
| US-5583213-A | CONTACTING SULFATED POLYSACCHARIDE SALT WITH CATION EXCHANGE RESIN TO FORM FREE ACID, THEN WITH TETRAALKYLAMMONIUM HYDROXIDE TO FORM AMMONIUM SALT, REACTING WITH COUPLING AGENT IN APROTIC SOLVENT TO ACTIVATE | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1996-12-10 | — | — | US | claimed |
| WO-1996035722-A1 | PROCESS TO ACTIVATE SULFATED POLYSACCHARIDES | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1996-11-14 | — | — | WO | claimed |
| WO-1996029094-A1 | PRODUCING IMMUNOGENIC CONSTRUCTS USING SOLUBLE CARBOHYDRATES ACTIVATED VIA ORGANIC CYANYLATING REAGENTS | LEES ANDREW (US) | 1996-09-26 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160331824-A1 | MULTIVALENT MENINGOCOCCAL CONJUGATES AND METHODS FOR PREPARING CONJUGATES | C1QBP, CFB, CFH | HSPB1 877/4885CA1 3701/4885CA2 3161/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.